Skip to main content
Premium Trial:

Request an Annual Quote

Jack Goldstein, Dennis Rossi, Garry Miyada, Maria Carles, SuperArray Bioscience, Genewave

Premium

People in the News

Jack Goldstein has joined Illumina's board of directors, the company said this week.

Goldstein most recently served as president and chief operating officer of Chiron until it was acquired by Novartis in April. Prior to Chiron, he spent two years as a general partner at Windamere Venture Partners, preceded by four years at Applied Imaging, first as president and CEO and then later as chairman.

Goldstein spent over a decade at Ortho Diagnostic Systems, a Johnson & Johnson company, in various executive positions including four years as president. He was earlier vice president of R&D at a division of Baxter Healthcare, Illumina said.


Dennis Rossi, Gene Logic's senior vice-president and general manager for genomics, resigned for personal reasons and to pursue other career opportunities, Gene Logic said last week (see Briefs, this issue).


Garry Miyada joined NuGEN Technologies as vice-president of product development, the company said last week.

Miyada spent the past 14 years at Affymetrix, where he held several positions, including senior director of expression product development. Prior to Affymetrix, he spent five years as a research scientist at Syva.

Miyada was a post-doctoral fellow at the Beckman Research Institute of the City of Hope. He received his PhD in molecular biology from the University of California, Los Angeles, and a BA in biochemistry and molecular biology from the University of California, Santa Barbara.


Maria Carles has been named vice president of scientific operations at Gwathmey, the company said this week.

She joins the array-based diagnostics firm from the Scripps Research Institute where she worked in the molecular and experimental medicine department.

Carles holds degrees in drug targeting, immunology, and microbiology from Northeastern University.

 

New Product Watch

SuperArray Bioscience last week launched its ArrayGrade FFPE RNA Isolation Kit for isolating RNA from formalin-fixed paraffin-embedded samples for microarray-based gene expression analysis.

The company claims the kit can help increase percent positive calls on high-density microarrays by reversing more of the cross-links introduced by the archiving process and recommended its use in cancer and pathology research.


Genewave last week launched AmpliSlide 570/670 A, the first in its line of AmpliSlide microarray slides.

According to Genewave, AmpliSlide 570/670 A is designed for two-color DNA microarray experiments. The slide uses a fluorescence-amplifying dielectric coating to provide up to 16-fold signal enhancement balanced in both colors, Genewave said.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.